$3.92
▼ $-0.03
(-0.76%)
Vol 1.7M
12
Quality Score
ok
Deep Check
2/5
ok
Rev ✓
NI ✓
>IPO ✗
Mkt Cap
$1.0B
P/E
24.6
ROE
19.2%
Margin
10.4%
D/E
7.62
Beta
1.65
52W
$6–$10
Wall Street Consensus
12 analysts · Apr 20262
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
91.7%
Buy Rating
Price Chart
Similar Stocks
GYRE
Gyre Therapeutics Inc
P/E 96.5
$641.7M
PURR
Hyperliquid Strategies Inc
ALLO
Allogene Therapeutics Inc
$307.9M
PRME
Prime Medicine Inc
$626.4M
OCGN
Ocugen Inc
$421.6M
IRWD
Ironwood Pharmaceuticals Inc
P/E 19.2
$548.2M
PROK
Prokidney Corp
$673.9M
TECX
Tectonic Therapeutic Inc
$390.4M
KYTX
Kyverna Therapeutics Inc
$537.0M
EIKN
Eikon Therapeutics Inc
Earnings
Beat rate: 100.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.09 | $0.10 | +$0.01 |
| Sep 2025 | $0.07 | $0.15 | +$0.08 |
| Jun 2025 | $0.06 | $0.10 | +$0.04 |
| Mar 2025 | $0.06 | $0.06 | +$0.00 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 16.2% | 16.2% | 16.2% | 19.2% | 19.2% | 19.2% |
| P/E (TTM) | 28.05 | 32.97 | 31.41 | 27.75 | 24.38 | 24.56 |
| Net Margin | 9.8% | 8.8% | 8.8% | 10.4% | 10.4% | 10.4% |
| Gross Margin | 81.0% | 81.5% | 81.5% | 82.0% | 82.0% | 82.0% |
| D/E Ratio | 8.52 | 8.52 | 8.52 | 7.62 | 7.62 | 7.62 |
| Current Ratio | 4.39 | 4.39 | 4.39 | 4.41 | 4.41 | 4.41 |
Key Ratios
ROA (TTM)
14.3%
P/S (TTM)
2.55
P/B
7.3
EPS (TTM)
$0.27
CF/Share
$0.01
Rev Growth 3Y
+10.5%
52W High
$9.71
52W Low
$5.79
$5.79
52-Week Range
$9.71
How does MDXG compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
MDXG valuation vs Biotechnology peers
P/E ratio
24.6
▲
31%
above
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
2.6
▼
80%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
7.3
▲
198%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
MDXG profitability vs Biotechnology peers
ROE
19.2%
▲
128%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
10.4%
▲
104%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
82.0%
▲
4%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
14.3%
▲
131%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
MDXG financial health vs Biotechnology peers
D/E ratio
7.6
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
4.4
▼
1%
below
peers
(4.4)
vs Peers
vs Industry
In line
Beta
1.7
▲
70%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
MDXG fundamentals radar
MDXG
Peer median
Industry
MDXG profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
MDXG vs peers: key metrics
Latest News
No related news yet